Seminars in Radiation Oncology
Volume 17, Issue 2 , Pages 99-107 , April 2007

Current Management for Late Normal Tissue Injury: Radiation-Induced Fibrosis and Necrosis

  • Sylvie Delanian, MD, PhD

      Affiliations

    • Oncologie-Radioth́rapie, Hôpital Saint-Louis, APHP, Paris, France.
    • Corresponding Author InformationAddress reprint requests to SylvieDelanian, MD, PhD, Oncologie-Radiothérapie, Hôpital Saint-Louis, APHP, 1 rue Claude Vellefaux, 75010 Paris, France.
    • ,
  • Jean-Louis Lefaix, PhD

      Affiliations

    • Commissariat à l’Energie Atomique, Direction des Sciences du Vivant, Département de Radiobiologie-Radiopathologie, Fontenay aux Roses, France.

References 

  1. Delanian S, Lefaix JL. The radiation-induced fibroatrophic process: Therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004;73:119–131
  2. Delanian S, Lefaix JL. Mature bone necrosis: from recent pathophysiological aspects to a new therapeutic action. [in French] Cancer Radiother. 2002;6:1–9
  3. Coleman N, Kelly L, Riese Daly N, et al. Phase II study of ibuprofen versus placebo for radiation-induced genitourinary side effects. Int J Radiat Oncol Biol Phys. 2002;54:191–194
  4. Geraci J, Mariano M, Jackson K. Amelioration of radiation nephropathy in rats by dexamethasone treatment after irradiation. Radiat Res. 1993;134:86–93
  5. Evans M, Graham M, Mahler P, et al. Use of steroids to suppress vascular response to radiation. Int J Radiat Oncol Biol Phys. 1987;13:563–567
  6. Moulder J. Pharmacological intervention to prevent or ameliorate chronic radiation injuries. Semin Radiat Oncol. 2003;13:73–84
  7. Delattre J, Rosenblum M, Thaler H, et al. A model of radiation myelopathy in the rat (Pathology, regional capillary changes and treatment with dexamethasone). Brain. 1988;111:1319–1336
  8. Gross N, Narine K, Wade R. Protective effect of corticosteroids on radiation pneumonitis in mice. Radiat Res. 1988;113:112–119
  9. Gross N, Holloway N, Narine K. Effects of some nonsteroidal anti-inflammatory agents on experimental radiation pneumonitis. Radiat Res. 1991;127:317–324
  10. Abergel A, Darcha C, Chevallier M, et al. Histological response in patients treated by interferon plus ribavarin for hepatitis C virus-related severe fibrosis. Eur J Gastroenterol Hepatol. 2004;16:1219–1227
  11. Ziesche R, Hofbauer E, Wittman K, et al. A preliminary study of long term treatment with interferon gamma 1b and low dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 1999;341:1264–1269
  12. Peter R, Gottlober P, Nadeshina N, et al. Interferon gamma in survivors of the Chernobyl power plant accident: new therapeutic option for radiation-induced fibrosis. Int J Radiat Oncol Biol Phys. 1999;45:147–152
  13. Gottlober P, Steinert M, Bahren W, et al. Interferon gamma in 5 patients with cutaneous radiation syndrome after radiation therapy. Int J Radiat Oncol Biol Phys. 2001;50:159–166
  14. Steen V, Medsger T, Rodnan G. D-penicillamine therapy in progressive systemic sclerosis. Ann Int Med. 1982;97:652–659
  15. Rambaldi A, Gluud C. Colchicine for alcoholic and non alcoholic liver fibrosis and cirrhosis. Cochrane Database Syst Rev. 2005;18:CD002148
  16. Selman M, Carillo G, Salas J, et al. Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: A controlled clinical trial. Chest. 1998;114:507–512
  17. Entzian P, Schlaak M, Seitzer U, et al. Anti-inflammatory and antifibrotic properties of colchicine: Implications for idiopathic pulmonary fibrosis. Lung. 1997;175:41–51
  18. Samlaska C, Winfield E. Pentoxifylline: Clinical review. J Am Acad Dematol. 1994;30:603–621
  19. Lefaix J-L, Delanian S, Vozenin M-C, et al. Striking regression of subcutaneous fibrosis induced by high doses of gamma rays using a combination of pentoxifylline and alpha-tocopherol: An experimental study. Int J Radiat Oncol Biol Phys. 1999;43:839–847
  20. Werner-Wasik M, Madoc-Jones H. Trental (pentoxifylline) relives pain from postradiation fibrosis. Int J Radiat Oncol Biol Phys. 1993;25:757–758
  21. Futran N, Trotti A, Gwede C. Pentoxifylline in the treatment of radiation-related soft tissue injury: Preliminary observations. Laryngoscope. 1997;107:391–395
  22. Okunieff P, Augustine E, Hicks JE, et al. Pentoxifylline in the treatment of radiation-induced fibrosis. J Clin Oncol. 2004;22:2207–2213
  23. Chua D, Lo C, Yuen J, et al. A pilot study of pentoxifylline in the treatment of radiation-induced trismus. Am J Clin Oncol. 2001;24:366–369
  24. Delanian S, Porcher R, Balla-Mekias S, et al. Randomized placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol. 2003;21:2545–2550
  25. Pasquier D, Hoelscher T, Schmutz J, et al. Hyperbaric oxygen therapy in the treatment of radio-induced lesions in normal tissues: A literature review. Radiother Oncol. 2004;72:1–13
  26. Carl U, Feldmeier J, Schmitt G, et al. Hyperbaric oxygen therapy for late sequelae in women receiving radiation after breast-conserving surgery. Int J Radiat Oncol Biol Phys. 2001;49:1029–1031
  27. Gothard L, Stanton A, McLaren J, et al. Non-randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphedema and tissue fibrosis after radiotherapy for early breast cancer. Radiother Oncol. 2004;70:217–224
  28. Pritchard J, Anand P, Broome J, et al. Double-blind randomized phase II study of hyperbaric oxygen in patients with radiation-induced brachial plexopathy. Radiother Oncol. 2001;58:279–286
  29. Ward W, Molteni A, Ts’ao C, et al. Functional responses of the pulmonary endothelium to thoracic irradiation in rats: Differential modification by D-penicillamine. Int J Radiat Oncol Biol Phys. 1987;13:1505–1509
  30. Moulder J, Fish B, Regner K, et al. Angiotensin II blockade reduces radiation-induced proliferation in experimental radiation nephropathy. Radiat Res. 2002;157:393–401
  31. Moulder J. Pharmacological intervention to prevent or ameliorate chronic radiation injuries. Sem Radiat Oncol. 2003;13:73–84
  32. Cohen E, Hussain S, Moulder J. Successful treatment of radiation nephropathy with angiotensin II blockade. Int J Radiat Oncol Biol Phys. 2003;55:190–193
  33. Haydont V, Mathe D, Bourgier C, et al. Induction of CTGF by TGFb1 in normal and radiation enteritis human smooth muscle cells: Smad/rho balance and therapeutic perspectives. Radiother Oncol. 2005;76:219–225
  34. Hauer-Jensen M, Fort C, Mehta J, et al. Influence of statins on postoperative wound complications after inguinal or ventral herniorrhaphy. Hernia. 2006;10:48–52
  35. Wang J, Zheng H, Qiu X, et al. Modulation of the intestinal response to ionizing radiation by anticoagulant and non anticoagulant heparins. Thromb Haemost. 2005;94:1054–1059
  36. Michelson A. In: Medical Aspects of Superoxide Dismutase (Life Chemistry Reports). United Kingdom: Harwood Academic Publishers; 1987;p. 1–142
  37. Niwa Y, Somiya K, Michelson A, et al. Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disorders (A preliminary study). Free Radic Res Commun. 1985;1:137–153
  38. Emerit J, Michelson A, Robert H, et al. Treatment with superoxide dismutase of two cases of radiation-induced sclerosis. [in French] Sem Hop. 1983;59:277–281
  39. Delanian S, Baillet F, Huart J, et al. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: Clinical trial. Radiother Oncol. 1994;32:12–20
  40. Lefaix J-L, Delanian S, Leplat J-J, et al. Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD: An experimental study. Int J Radiat Oncol Biol Phys. 1996;35:305–312
  41. Benyahia B, Campana F, Perdereau B, et al. The effects of superoxide dismutase topical treatment on human skin radiofibrosis: A pathological study. Breast. 1996;5:75–81
  42. Campana F, Zervoudis S, Perdereau B, et al. Topical superoxide dismutase reduces post-irradiation breast cancer fibrosis. J Cell Mol Med. 2004;8:109–116
  43. Delanian S, Bravard A, Martin M, et al. In vitro modulation by liposomal superoxide dismutase of the fibroblast phenotype in human skin with chronic radiotherapy damage. Radiother Oncol. 2001;58:325–331
  44. Vozenin-Brotons M-C, Sivan V, Gault N, et al. Anti-fibrotic action of Cu/Zn SOD is mediated by TGF-β1 repression and phenotypic reversion of myofibroblasts. Free Radic Biol Med. 2001;30:30–42
  45. Nielsen O, Overgaard J, Overgaard M, et al. Orgotein in radiation treatment of bladder cancer (A report on allergic reactions and lack of radioprotective effect). Acta Oncol. 1987;26:101–104
  46. Sanchy F, Milla A, Artola N, et al. Prevention of radiation-induced cystitis by orgotein: A randomized study. Anticancer Res. 1996;16:2025–2028
  47. Vujaskovic Z, Batanic-Haberle I, Rabbani Z, et al. A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase mimetic properties protects lungs from radiation-induced injury. Free Radic Biol Med. 2002;33:857–863
  48. Rabbani Z, Anscher M, Folz R, et al. Overexpression of extracellular superoxide dismutase reduces acute radiation-induced lung toxicity. BMC Cancer. 2005;5:59–72
  49. Epperly M, Epstein C, Travis E, et al. Decreased pulmonary radiation resistance of manganese superoxide dismutase (MnSOD)-deficient mice is corrected by human manganese superoxide dismutase-plasmid/liposome (SOD2-PL) intratracheal gene therapy. Radiat Res. 2000;154:365–374
  50. Lamproglu I, Magdelenat H, Boisserie G, et al. An experimental model of acute encephalopathy after total body irradiation in the rat: Effect of liposome entrapped Cu/Zn SOD. Int J Radiat Oncol Biol Phys. 1998;42:179–184
  51. Molla M, Gironella M, Salas A, et al. Protective effect of superoxide dismutase in radiation-induced intestinal inflammation. Int J Radiat Oncol Biol Phys. 2005;61:1159–1166
  52. Packer L, Weber S, Rimbach G. Molecular aspects of alpha-tocopherol antioxidant action and cell signaling. J Nutr. 2001;131:369S–373S
  53. Azzi A, Ricciarelli R, Zingg J-M. Non-oxidant molecular functions of alpha-tocopherol (vitamin E): Minireview. FEBS Lett. 2002;519:8–10
  54. Baillet F. Alpha-tocopherol treatment of radiofibrosis post-brachytherapy for breast cancer. Radiother Oncol. 1997;43(suppl 1):S3;(, abstr)
  55. Ferreira P, Fleck J, Diehl A, et al. Protective effect of alpha tocopherol in head neck cancer radiation-induced mucositis: A double blind randomized trial. Head Neck. 2004;26:313–321
  56. Eidelman R, Hollar D, Hebert P, et al. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med. 2004;164:1552–1556
  57. Miller E, Pastor-Bariuso R, Dalal D, et al. Meta-analysis: high dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37–46
  58. Bowry V, Stocker R. Tocopherol-mediated peroxidation: The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc. 1993;115:6029–6044
  59. Delanian S. Striking regression of radiation-induced fibrosis by a combination of pentoxifylline and tocopherol (case report). Br J Radiol. 1998;71:892–894
  60. Delanian S, Balla-Mekias S, Lefaix J-L. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol. 1999;17:3283–3290
  61. Delanian S, Porcher R, Rudant J, et al. Kinetics of response to long term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol. 2005;23:8570–8579
  62. Haddad P, Kalaghchi B, Amouzegar-Hashemi F. Pentoxifylline and Vitamin E combination for superficial radiation-induced fibrosis: A phase II clinical trial. Radiother Oncol. 2005;77:324–326
  63. Cosset J-M. Breur Gold Medal Award Lecture 2001: Irradiation accidents lessons for oncology. Radiother Oncol. 2002;63:1–10
  64. Gothard L, Cornes P, Earl J, et al. Double blind placebo-controlled randomized trial of vitamin E and pentoxifylline in patients with chronic arm lymphedema and fibrosis after surgery and radiotherapy for breast cancer. Radiother Oncol. 2004;73:133–139
  65. Georges C, Delanian S, Lefaix J-L. Resolution of progressive failed back surgery syndrome with a striking reduction of epidural fibrosis using combined pentoxifylline and tocopherol. Br J Radiol. 2004;77:885–887
  66. Hille A, Christiansen H, Pradier O, et al. Effect of pentoxifylline and tocopherol on radiation proctitis/ enteritis. Strahlenther Onkol. 2005;181:606–614
  67. Gothard L, Cornes P, Brooker S, et al. Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy. Radiother Oncol. 2005;75:334–341
  68. Letur-Könirsch H, Guis F, Delanian S. Major uterine restoration by radiation sequelae regression with a combination of pentoxifylline- tocopherol: A phase II study. Fertil Steril. 2002;77:1219–1226
  69. Ledee-Bataille N, Olivennes F, Lefaix J-L, et al. Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation program. Hum Reprod. 2002;17:1249–1253
  70. Laurent C, Pouget J-P, Voisin P. Modulation of DNA damage by pentoxifylline and alpha-tocopherol in skin fibroblasts exposed to gamma-rays. Radiat Res. 2005;164:63–72
  71. Laurent C, Voisin P, Pouget J-P. DNA damage in cultured skin microvascular endothelial cells exposed to gamma rays and treated by the combination pentoxifylline and alpha-tocopherol. Int J Radiat Biol. 2006;82:309–321
  72. Rodan G, Fleisch A. Biphosphonates: Mechanisms of action. J Clin Invest. 1996;97:2692–2696
  73. Dunn C, Galinat L, Wu H, et al. Demonstration of novel antiarthritic and anti-inflammatory effects of diphosphonates. J Pharmacol Exp Ther. 1993;226:1691–1698
  74. Ruggiero S, Mehrotra B, Rosenberg T, et al. osteonecrosis of the jaws associated with the use of biphosphonates: A review of 63 cases. J Oral Maxillofac Surg. 2004;62:527–534
  75. Fromigue O, Body J. Biphosphonates influence the proliferation and the maturation of normal human osteoblasts. J Endocrinol Invest. 2002;25:539–546
  76. Atula S, Powles T, Paterson A, et al. Extended safety profile of oral clodronate after long term use in primary breast cancer patients. Drug Saf. 2003;26:661–671
  77. McCloskey E, Selby P, Davies M, et al. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: Results of a double blind placebo-controlled 3-year study. J Bone Miner Res. 2004;19:728–736
  78. Johnston C, Williams J, Elder A, et al. Inflammatory cell recruitment following thoracic irradiation. Exp Lung Res. 2004;30:369–382
  79. Diel I, Solomayer E, Costa S, et al. Reduction in new metastasis in breast cancer with adjuvant clodronate treatment. N Engl J Med. 1998;6:357–363
  80. Froom P, Elmalah I, Braester A, et al. Clodronate in myelofibrosis: A case report. Am J Med Sci. 2002;323:115–116
  81. Tibbles P, Edelsberg J. Hyperbaric-oxygen therapy (Review article). N Engl J Med. 1996;334:1642–1648
  82. Delanian S, Depondt J, Lefaix J-L. Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial. Head Neck. 2005;27:114–123
  83. Annane D, Depondt J, Aubert P, et al. Hyperbaric oxygen therapy for radionecrosis of the jaw: A randomized placebo-controlled, double blind, trial from the ORN96 Study Group. J Clin Oncol. 2004;22:4893–4900
  84. Marx R, Johnson R. Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol. 1987;64:379–390
  85. Bennett M, Feldmeier J, Hampson N, et al. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2005;20:CD005005
  86. Mayer R, Klemen H, Quehenberger F, et al. Hyperbaric oxygen: An effective tool to treat radiation morbidity in prostate cancer. Radiother Oncol. 2001;61:151–156
  87. Gouello JP, Bouachour G, Person B, et al. Contribution of hyperbaric oxygen in radiation-induced digestive disorders: 36 observations. Presse Med. 1999;28:1053–1057
  88. Corman J, McClure D, Pritchett R, et al. Treatment of radiation-induced hemorrhagic cystitis with hyperbaric oxygen. J Urol. 2003;169:2200–2202
  89. Bevers R, Bakker D, Kurth K. Hyperbaric oxygen treatment for haemorrhagic radiation cystitis. Lancet. 1995;346:803–805
  90. Dion M, Hussey D, Doornbos J, et al. Preliminary study of pentoxifylline in the treatment of late radiation soft tissue necrosis. Int J Radiat Oncol Biol Phys. 1990;19:401–407
  91. Fischer M, Wohlrab J, Marsch W. Crux medicorum ulcerated radiation-induced fibrosis successful therapy with pentoxifylline and vitamin E (case report). Eur J Dermatol. 2001;11:38–40
  92. Delanian S, Lefaix J-L. Complete healing of severe osteoradionecrosis by treatment combining pentoxifylline, tocopherol and Clodronate (case report). Br J Radiol. 2002;75:467–469
  93. Delanian S, Pradat P-F, Maisonobe T, et al. New data in the treatment of radiation-induced plexitis (in French). 2005;Presented at the meeting of Société Française de Neurologie. Paris La Villette, France, December 2,

PII: S1053-4296(06)00107-X

doi: 10.1016/j.semradonc.2006.11.006

Seminars in Radiation Oncology
Volume 17, Issue 2 , Pages 99-107 , April 2007

Article Tools